Novel Dual-Plasmid Transfection System Improves Titer And Product Quality In AAV Manufacturing
Innovative Platforms For Improved Viral Vector Development And Scale-Up
Enhancing Titres of Therapeutic Viral Vectors using the Transgene Repression in Vector Production TRiP System
Advancing Gene Therapy Development with a Multi Type AAV Affinity Resin
Achieving rAAV Bioreactor Titer of 1E15 vgL With Novel Plasmid Transient Transfection Platform
Podcast: Achieving Better AAV Productivity
LV: TetraVecta™ System Brochure
Interim results for the six months ended in 30 June 2024
23 September 2024
Transduction Patterns of Pseudotyped Lentiviral Vectors in the Nervous System
1st January 2004
Transduction of Photoreceptors With Equine Infectious Anemia Virus Lentiviral Vectors: Safety and Biodistribution of StarGen for Stargardt Disease
18th April 2013
Time‐Dependent Sorption Behavior of Lentiviral Vectors During Anion‐Exchange Chromatography
14th June 2023
The Integration Profile of EIAV-Based Vectors
October 2006
